Ducks are lining up: Inaugural drilling at Mamba’s Canary uranium project set to begin shortly
Mamba Exploration will drill up to 1,500m with one hole focusing on the highest priority target area along the northern electromagnetic corridor That hole will [more…]
ASX Health Stocks: Clarity Pharma says its prostate cancer treatment has achieved ‘complete response’
Clarity Pharma doses first patient with two cycles of 67Cu-SAR-bisPSMA at 8GBq The patient achieved a complete response to treatment This was part of Clarity’s [more…]
Soil sampling defines sweet uranium anomaly at Oceana’s Napperby project
Oceana Lithium soil sampling defines large uranium anomaly at Napperby project in the NT Hyperspectral data supports interpretation that ‘roll-front’ style uranium mineralisation is present [more…]
Marmota’s luck shines bright as drilling strikes gold at Goolagong
Marmota makes potential new gold discovery at the Goolagong target in South Australia Hole 23MT184 returned an intersection of 2m at 0.64g/t gold Gold grades [more…]
Successful brine extraction paves way for Green River lithium development
Supersaturated brine sampled at Green River was drilled to a depth of 3,416.81m and continued to flow into the tubing The flow of supersaturated brine [more…]
Top 10 at 10: Silver hits and a big lithium rally
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights Tesla jumps 15pc, Apple rallies, but upcoming Fed meeting casts shadow over markets
ASX to lift on the back of another rally on Wall Street Tesla jumped +15pc following Elon Musk’s trip to China US Fed meeting [more…]
Delving into Alaska’s prolific Fairbanks mining district, Felix Gold looks ripe for the picking
Felix is one of the largest claim holders in the Fairbanks gold mining district The Grant Mine has a proven 364,000oz brownfields resource Maiden resource [more…]
ASX medtechs poised to transform healthcare with upcoming catalysts in 2024 – Part 1
Several ASX medtech companies have upcoming catalysts in 2024 as they look to transform healthcare Imricor preparing to treat its first ventricular tachycardia patient this [more…]
FREE WHELAN: Long on Japan is big everywhere
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in [more…]
